Montelukast Prescribing at THE MAPLES
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
850
Total Quantity
19.9K
NHS Cost
£1.0K
vs National Avg
+24.1%
THE MAPLES prescribed 850 items of Montelukast over the last 12 months at a cost of £1,006 to the NHS. This is 24.1% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
77
Jun 2026
75
Jun 2026
66
Jun 2026
73
Jun 2026
71
Jun 2026
71
Jun 2026
62
Jun 2026
75
Jun 2026
74
Jun 2026
69
Jun 2026
72
Jun 2026
65
Prescribing Details
| Total Items | 850 |
|---|---|
| Total Quantity | 19,943 |
| Total NHS Cost | £1,006 |
| Presentations | 4 different forms |
| vs National Average | +24.1% |
Montelukast Prescribing Comparison
| This practice | 850 items |
|---|---|
| National average per practice | 685 items |
| Difference | +24.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.